362 related articles for article (PubMed ID: 2144979)
1. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
Schumacher WA; Heran CL; Ogletree ML
Eicosanoids; 1990; 3(2):87-93. PubMed ID: 2144979
[TBL] [Abstract][Full Text] [Related]
2. Protamine-heparin-induced pulmonary hypertension in pigs: effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation.
Nuttall GA; Murray MJ; Bowie EJ
Anesthesiology; 1991 Jan; 74(1):138-45. PubMed ID: 1824742
[TBL] [Abstract][Full Text] [Related]
3. Activity of the short-acting thromboxane receptor antagonist, SQ 30,741, in thrombolytic and vasospastic models in monkeys.
Schumacher WA; Heran CL; Hartl KS; Ogletree ML
J Pharmacol Exp Ther; 1990 May; 253(2):841-6. PubMed ID: 2140131
[TBL] [Abstract][Full Text] [Related]
4. Thromboxane receptor activation during bronchospasm induced by platelet-activating factor.
Schumacher WA; Steinbacher TE
J Lipid Mediat; 1991; 4(1):97-110. PubMed ID: 1832573
[TBL] [Abstract][Full Text] [Related]
5. [Losartan prevents pulmonary hypertension induced by a thromboxane A2 analog].
Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW
Arch Mal Coeur Vaiss; 1994 Aug; 87(8):971-4. PubMed ID: 7755474
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.
Ogletree ML; Harris DN; Heran CL; Phillips MB; Michel IM; Goldenberg HJ
Eicosanoids; 1988; 1(2):85-91. PubMed ID: 2856188
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin B2-induced pulmonary hypertension is mediated by TxA2/PGH2 receptor stimulation.
Liu F; Orr JA; Wu JY
Am J Physiol; 1994 Nov; 267(5 Pt 1):L602-8. PubMed ID: 7977770
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
Conzen PF; Habazettl H; Gutmann R; Hobbhahn J; Goetz AE; Peter K; Brendel W
Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
[TBL] [Abstract][Full Text] [Related]
9. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
10. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
[TBL] [Abstract][Full Text] [Related]
11. Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep.
Montalescot G; Lowenstein E; Ogletree ML; Greene EM; Robinson DR; Hartl K; Zapol WM
Circulation; 1990 Nov; 82(5):1765-77. PubMed ID: 2146041
[TBL] [Abstract][Full Text] [Related]
12. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed.
McMahon TJ; Hood JS; Nossaman BD; Ibrahim IN; Feng CJ; Kadowitz PJ
J Appl Physiol (1985); 1991 Nov; 71(5):2012-8. PubMed ID: 1837015
[TBL] [Abstract][Full Text] [Related]
13. Photoaffinity receptor antagonist for human platelet thromboxane A2/prostaglandin H2 receptors.
Mais DE; Liel N; Halushka PV
Biochem Pharmacol; 1990 Oct; 40(7):1457-61. PubMed ID: 2145838
[TBL] [Abstract][Full Text] [Related]
14. Heparin-protamine reactions in pigs: role of oxygen-derived free radicals.
Vollmar B; Conzen PF; Habazettl H; Yekebas E; Peter K
J Appl Physiol (1985); 1993 May; 74(5):2412-20. PubMed ID: 8335575
[TBL] [Abstract][Full Text] [Related]
15. Thromboxane receptor blockade does not attenuate pulmonary pressor response in porcine single lung transplantation.
Kukkonen S; Heikkilä L; Verkkala K; Mattila S; Toivonen H
J Heart Lung Transplant; 1996 Apr; 15(4):409-14. PubMed ID: 8732601
[TBL] [Abstract][Full Text] [Related]
16. Roles of platelet-activating factor and thromboxane in group B Streptococcus-induced pulmonary hypertension in piglets.
Pinheiro JM; Pitt BR; Gillis CN
Pediatr Res; 1989 Nov; 26(5):420-4. PubMed ID: 2682499
[TBL] [Abstract][Full Text] [Related]
17. Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
Bertolino F; Valentin JP; Maffre M; Jover B; Bessac AM; John GW
J Pharmacol Exp Ther; 1994 Feb; 268(2):747-52. PubMed ID: 8113986
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.
Ashton JH; Schmitz JM; Campbell WB; Ogletree ML; Raheja S; Taylor AL; Fitzgerald C; Buja LM; Willerson JT
Circ Res; 1986 Nov; 59(5):568-78. PubMed ID: 3542279
[TBL] [Abstract][Full Text] [Related]
20. Effects of the prostaglandin H2/thromboxane A2 antagonist BM 13.177 on human platelets.
Patscheke H; Stegmeier K
Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():371-3. PubMed ID: 3159225
[No Abstract] [Full Text] [Related]
[Next] [New Search]
